Doxil Injection, Suspension, Liposomal
Product Images NDC 0338-9667

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxil (NDC 0338-9667). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01-doxil-structural-formula (Image 01 Doxil Structural Formula)

Chemical structure diagram of doxorubicin hydrochloride, the active ingredient in DOXIL injection, suspension, liposomal. The diagram shows the molecular arrangement including rings, hydroxyl, methoxy, and amino groups with hydrochloride indicated.*

FDA Label Image

Image-02-mpge-dspe-structural-formula (Image 02 Mpge Dspe Structural Formula)

Chemical structure diagram of the active ingredient doxorubicin hydrochloride showing the molecular composition with polyethylene glycol, phosphate, and fatty acid chains, including a sodium ion (Na+). The structure includes a polymer chain segment represented with n approximately 45 units.*

FDA Label Image

Image-03-hspc-structural-formula (Image 03 Hspc Structural Formula)

Chemical structure diagram showing a phosphatidylcholine lipid molecule with variable alkyl chain lengths (m, n = 14 or 16). This structure is part of the formulation components of DOXIL (doxorubicin hydrochloride) liposomal injection.*

FDA Label Image

Image-04-stealth-liposome (Image 04 Stealth Liposome)

Illustration of the liposomal structure of DOXIL (doxorubicin hydrochloride) showing the MPEG-DSPE coating, the liposomal bilayer, and the aqueous core containing entrapped doxorubicin HCl.*

FDA Label Image

Image-05-figure-01 (Image 05 Figure 01)

A Kaplan-Meier survival curve chart showing the percent of subjects progression-free over time (months) for two groups: DOXIL plus Bortezomib and Bortezomib alone. The chart includes censored data points and a risk table below the x-axis indicating the number of subjects at risk over time for each group. Statistical values such as p-value (< 0.0001) and hazard ratio (HR) with 95% confidence interval are also shown.*

FDA Label Image

Image-06-doxil-20mg-10ml-container-label (Image 06 Doxil 20mg 10ml Container Label)

DOXIL (doxorubicin hydrochloride liposome injection) 20 mg in 10 mL (2 mg/mL) single-dose vial label. It includes warnings that the product is liposomal formulation and should not be substituted for doxorubicin hydrochloride. Intended for intravenous infusion only. Storage instructions specify refrigeration at 2°-8°C and to not freeze. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Image-07-doxil-20mg-10ml-carton-label (Image 07 Doxil 20mg 10ml Carton Label)

DOXIL 2 mg/mL liposome injection vial carton label for doxorubicin hydrochloride. The label indicates 20 mg in 10 mL single-dose vial, for intravenous infusion only after dilution. It cautions against substituting for doxorubicin hydrochloride and instructs to use 5% dextrose injection for dilution. Manufactured for Baxter Healthcare Corporation, made in Germany.*

FDA Label Image

Image-08-doxil-50mg-25ml-container-label (Image 08 Doxil 50mg 25ml Container Label)

DOXIL 2 mg/mL injection, suspension, liposomal in a single-dose vial containing 50 mg in 25 mL. The label highlights it is a liposomal formulation of doxorubicin hydrochloride for intravenous infusion only, with storage instructions to refrigerate at 2°-8°C and not freeze. Baxter Healthcare Corporation is the labeler.*

FDA Label Image

Image-09-doxil-50mg-25ml-carton-label (Image 09 Doxil 50mg 25ml Carton Label)

DOXIL (doxorubicin hydrochloride liposome injection) 2 mg/mL carton label showing a 50 mg in 25 mL single-dose vial. The label warns not to substitute for doxorubicin hydrochloride, states intravenous infusion use only after dilution, and notes refrigeration requirements. Manufactured for Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.